“ Knowing we’re on the path to delivering transformative treatments quickly and widely sustains my passion and commitment" ”
In Conversation
“ Our mission is straightforward yet ambitious: to make a meaningful difference for patients and caregivers by addressing areas that have been largely overlooked ”
“ Although UPSA does not have the same scale of R&D resources as larger pharmaceutical companies, our focus on clinical and formula innovations allows us to bring… ”
“ Unlike gene therapies, our technology does not require immune system suppression, as it uses the patient’s own cells. This significantly reduces complexity and risk while maintaining… ”
“ We have prioritized understanding the market potential and the patient populations we are targeting. In particular, our work in precision oncology and especially precision immunology has… ”
“ Despite having one of the most advanced healthcare systems in the world, Switzerland is now ranked sixth in Europe for innovative drug access and ninth for… ”
“ Swissmedic is well-equipped to address the challenges in the ATMP field and is ready to help shape the future of drug regulation ”
“ Our goal is to make Switzerland the number one medtech market in the world by driving innovation and attracting investment ”
“ AMR is important today, but the bigger issue is what could happen in the future ”
“ The pro-innovation environment and robust support for R&D are key reasons why Switzerland remains such a vital part of MSD’s global strategy. Our continued investment reflects… ”
“ The foundation for a successful investment project is laid in the very early stages, with the right setup and a solid organization ”
“ We must secure a sustainable future where innovation and patient care thrive together ”
